Argon: The 'lazy' noble gas with organoprotective properties

European Journal of Anaesthesiology

Volumn 29, Issue 12, 2012, Pages 549-551

  Coburn, Mark ^a   Sanders, Robert D ^b   Ma, Daqing ^c   Fries, Michael ^a   Rex, Steffen ^d   Magalon, Guy ^e   Rossaint, Rolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ARGON; HELIUM; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROGEN; OXYGEN; XENON;

ASTROCYTE; ATMOSPHERIC PRESSURE; BIOLOGICAL ACTIVITY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL SURVIVAL; CORTI ORGAN; COST EFFECTIVENESS ANALYSIS; HAIR CELL; HEART INFARCTION; HEART PROTECTION; HIPPOCAMPUS; IN VITRO STUDY; KIDNEY TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; RENAL PROTECTION; REPERFUSION INJURY; REVIEW;

ANIMALS; ARGON; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEART; HUMANS; KIDNEY; NEUROPROTECTIVE AGENTS; NOBLE GASES; OXYGEN; RATS; XENON;

EID: 84872258877     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328357bfdd     Document Type: Review

References (32)

1. Haynes WM, Lide DR. CRC handbook of chemistry and physics. 92nd ed. In: Haynes WM, Lide DR, editors. London, GB: Taylor & Francis Ltd; 2011; ISBN-13: 978-1439855119.
2. Rabinovich VA, Selover TB. Thermophysical properties of neon, argon, krypton and xenon. In: Rabinovich VA, Selover TB, editors. Washington DC: Hemisphere Pub. Corp; 1988; ISBN: 08911667509780891166757.
3. Behnke AR, Yarbrough OD. Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. Am J Physiol 1939; 126:409-415.
4. Miller KW, PatonWDM, Smith EB, Smith RA. Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology 1972; 36:339-351.
5. Koblin DD, Fang Z, Eger E, et al. Minimum alveolar concentration of noble gases, nitrogen, and sulfar hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 1998; 87:419-424.
6. Soldatov PE, D'iachenko AI, Pavlov BN, et al. Survival of laboratory animals in argon-containing hypoxic gaseous environments. Aviakosm Ekolog Med 1998; 32:33-37.
7. Soldatov PE, Smirnov IA, Smolenskaia TS, et al. Physiologically active argon-based gas mixtures as a means of creating fire-safe gaseous environments in pressurized modules of varying purpose. Aviakosm Ekolog Med 2008; 42:45-52.
8. Antonov AA, Ershova TA. Retention of the skill to perform adaptive biocontrol of bioelectrical activity synchronization in the human brain cortex in an argon-nitrogen-oxygen atmosphere with various oxygen content. Aviakosm Ekolog Med 2009; 43:27-31.
9. Yarin YM, Amarjargal N, Fuchs J, et al. Argon protects hypoxia-, cisplatinand gentamycin-exposed hair cells in the newborn rat's organ of corti. Hear Res 2005; 201:1-9.
10. Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460:232-236.
11. Loetscher PD, Rossaint J, Rossaint R, et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009; 13:R206.
12. Ryang YM, Fahlenkamp AV, Rossaint R, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2011; 39:1448-1453.
13. David HN, Haelewyn B, Degoulet M, et al. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 2012; 7:e30934.
14. Brücken A, Fera C, Meinhardt A, et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Circulation 2011; 124:A9362.
15. Zhuang L, Yang T, Zhao H, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012; 40:1724-1730.
16. Abraini JH, Kriem B, Balon N, et al. Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 2003; 96:746-749.
17. Bickler PE, Warner DS, Stratmann G, Schuyler JA. Gamma-Aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth Analg 2003; 97:564-571.
18. Schwartz-Bloom RD, Miller KA, Evenson DA, et al. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience 2000; 98:471-484.
19. Seto T, Isogai H, Ozaki M, Nosaka S. Noble gas binding to human serum albumin using docking simulation: nonimmobilizers and anesthetics bind to different sites. Anesth Analg 2008; 107:1223-1228.
20. Fahlenkamp AV, Rossaint R, Haase H, et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signalling in neurons and glial cells. Eur J Pharmacol 2012; 647:104-111.
21. Rizvi M, Jawad N, Li Y, et al. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exper Biol Med 2010; 235:886-891.
22. Irani Y, Pype JL, Martin AR, et al. Noble gas (argon and xenon)-saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation. Nephron Extra 2011; 1:272-282.
23. Preckel B, Weber NC, Sanders RD, et al. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006; 105:187-197.
24. Brücken A, Coburn M, Rex S, et al. Xenon: possible role in anaesthesia and intensive care medicine. Anaesthesist 2010; 59:883-895.
25. Derwall M, Coburn M, Rex S, et al. Xenon-recent developments and future perspectives. Minerva Anestesiol 2008; 75:37-45.
26. Pagel PS, Krolikowski JG, Shim YH, et al. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007; 105:562-569.
27. Dickinson R, Franks NP. Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care 2010; 14:229.
28. Coburn M, Rossaint R. Argon in the fast lane: noble gases and their neuroprotective effects. Crit Care Med 2012; 40:1965-1966.
29. Sanders RD, Ma D, Maze M. Argon neuroprotection. Crit Care 2010; 14:117.
30. Ezzeddine MA. From xenon to argon: a more clinically accessible neuroprotectant? Crit Care Med 2011; 39:1589-1590.
31. Ruzicka J, Benes J, Bolek L, Markvartova V. Biological effects of noble gases. Physiol Res 2007; 56:S39-S44.
32. Liu W, Khatibi N, Sridharan A, Zhang JH. Application of medical gases in the field of neurobiology. Med Gas Res 2011; 1:13.